Related Experiment Videos
Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities
1Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, 48109, USA.
The Journal of Biological Chemistry
|March 8, 1996
Summary
The RET receptor tyrosine kinase is crucial for development and linked to MEN2B. MEN2B mutations alter RET autophosphorylation, affecting signaling and potentially causing a more aggressive disease phenotype.
Area of Science:
- Molecular biology
- Oncology
- Developmental biology
Background:
- The c-ret proto-oncogene encodes a receptor tyrosine kinase vital for neural crest and kidney development.
- Germline mutations in RET are implicated in multiple endocrine neoplasia (MEN) 2A/2B, familial medullary thyroid carcinoma (FMTC), and Hirschsprung's disease.
- The precise signal transduction mechanisms of RET, particularly in disease states, remain largely unelucidated.
Purpose of the Study:
- To investigate the autophosphorylation patterns of wild-type RET and MEN mutants.
- To elucidate the molecular mechanisms underlying RET-associated diseases.
- To understand how RET mutations impact receptor signaling capabilities.
Main Methods:
- Site-directed mutagenesis was employed to create RET mutants.
- Phosphopeptide mapping was utilized to analyze autophosphorylation sites.
- Analysis focused on wild-type RET and MEN2B mutant variants.
Main Results:
- Six autophosphorylation sites were identified in wild-type RET.
- The MEN2B RET mutant exhibited a lack of phosphorylation at Tyr-1096.
- This MEN2B mutation also created a novel phosphorylation site and reduced Grb2 binding.
Conclusions:
- Altered autophosphorylation patterns in the MEN2B RET mutant suggest a mechanism for its aggressive phenotype.
- Changes in RET phosphorylation impact its signaling capabilities.
- Understanding these alterations is key to deciphering RET-driven disease pathogenesis.